Ambrisentan Tablets 5 mg and 10 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 5 mg and 10 mg
Reference Brands: Letairis®(US & EU); Volibris®(EU)
Category: Orphan Drugs
Ambrisentan is an endothelin receptor antagonist that blocks endothelin-1, a substance that constricts blood vessels. It relaxes pulmonary arteries, decreasing blood pressure. Benefits include improved exercise capacity, symptom relief, and slowed disease progression in pulmonary arterial hypertension patients, enhancing quality of life.
Product Description: Ambrisentan tablets, marketed as Letairis® and Volibris®, are approved in the US and EU for pulmonary arterial hypertension (PAH). Regulatory dossiers include comprehensive clinical trial data, manufacturing standards, and safety profiles, supporting approval by the FDA and EMA. These dossiers demonstrate Ambrisentan’s efficacy in improving exercise capacity and reducing PAH symptoms. Available in 5 mg and 10 mg tablets, dosing can be tailored to patient response. For detailed insights on regulatory processes, dossier submissions, and market approvals in the EU and US, visit PharmaTradz, your trusted source for pharmaceutical regulatory insights and industry updates.
Ambrisentan Tablets — third party manufacturing & bulk supply
Ambrisentan Tablets 5 mg and 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Ambrisentan Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ambrisentan Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Pasireotide Diaspartate
Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg
Form: Injection
Reference Brands: Signifor (USA/EU)
View Details
Sepiapterin
Strength:
1000 mg, 250 mg
Form: Tablets / oral powder
Reference Brands: Sephience (USA/EU)
View Details
Glycerol Phenylbutyrate
Strength:
1.1 g/mL
Form: Oral Solution
Reference Brands: Ravicti (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
